The text trap: If you select numbers and the status bar stays blank (or only shows the Count), your numbers are formatted as text—and Excel can't sum words! This tells you that you should click the ...

Just describe your edits to ChatGPT, and the Photoshop, Acrobat, and Express apps will do it for you or surface the tool you need. Just describe your edits to ChatGPT, and the Photoshop, Acrobat, ...

In the world of gaming, peripherals are far more than just accessories—they are extensions of your skills and the key to elevating performance. A well-chosen mechanical keyboard and gaming mouse can ...

One of the most important rules of cell phone use? Don’t go over your data limit. Overages can lead to a more expensive bill than you’d been planning for. Indeed, anyone who has a cell phone-armed ...

A Stanford-led team has replaced toxic pre-transplant chemotherapy with a targeted antibody, allowing children with Fanconi anemia to receive stem cell transplants safely. The antibody, briquilimab, ...

Jesse Todd, CEO of EncompaaS, is a SaaS expert specializing in information management and risk mitigation for Fortune 500 companies. AI has the potential to transform how organizations operate, but ...

Tariffs and uncertainty were already making the economy hard to read. The loss of government data during the shutdown has made the situation much worse. By Ben Casselman and Colby Smith Tariffs are at ...

Durable reprogramming of human T cells may now be possible thanks to a new technique based on the CRISPRoff and CRISPRon methodology. Researchers from the Arc Institute, Gladstone Institutes, and the ...

As they prepare to meet in 10 days on interest rates, Federal Reserve officials are very divided over a key question: How worried they ought to be about the U.S. labor market. “Some folks are less ...

COLUMBUS, Ohio — A new Amazon data center under construction in Hilliard is drawing additional scrutiny after the company proposed building a fuel cell facility to help power it. Some neighbors who ...

Cabaletta Bio’s CAR-T cell therapy has eliminated the overreactive B cells of two patients with an autoimmune disease without preconditioning chemotherapy, pleasing investors and analysts while ...